Please use this identifier to cite or link to this item:
http://hdl.handle.net/10261/8196Share/Export:
 SHARE
BASE
|
|
| Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
| Title: | Heterocyclic inhibitors of glycogen synthase kinase GSK-3 |
Authors: | Wandosell, Francisco CSIC ORCID ; Martínez, Ana CSIC ORCID ; Pérez Martín, María Concepción; Dorronsoro Díaz, Isabel; Alonso Cascón, Mercedes; Castro, Ana CSIC ORCID; Moreno Muñoz, Francisco José | Keywords: | Inhibitors of GSK-3 | Issue Date: | 16-Mar-2006 | Abstract: | Compounds of formula (II) where Ra, Rb, Y and X take various meanings are of use in the preparation of a pharmaceutical formulation, for example in the treatment of a disease in which GSK-3 is involved, including Alzheimer's disease or the non-dependent insulin diabetes mellitus, or hyperproliferative disease such as cancer, displasias or metaplasias of tissue, psoriasis, arterosclerosis or restenosis | Description: | Filing Date: 2006-02-17 | URI: | http://hdl.handle.net/10261/8196 |
| Appears in Collections: | (CBM) Patentes |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| F.Wandosell_AU_2006_200668_A1.pdf | 936,73 kB | Adobe PDF |  View/Open |
Review this work
Page view(s)
273
checked on May 17, 2022
Download(s)
119
checked on May 17, 2022
Google ScholarTM
Check
WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.